(HealthDay)—Negative pigment network (NPN) can be used to distinguish melanoma from Spitz nevus and other benign lesions, according to a study published online Oct. 11 in the Journal of the American Academy of Dermatology.
Oct 25, 2012
0
0
Peter B. Bach, M.D., of the Memorial Sloan-Kettering Cancer Center, New York, and colleagues conducted a systematic review to examine the evidence regarding the benefits and harms of low-dose computerized tomography (LDCT) ...
May 20, 2012
0
0
The trefoil factor 3 (TFF3) protein protects and maintains the integrity of the epithelial surface in the normal breast. New research has found that while TFF3 protein expression is higher in well-differentiated low grade ...
Feb 16, 2012
0
0
A deep learning method with a convolutional neural network (CNN) can support the evaluation of small solid renal masses in dynamic CT images with acceptable diagnostic performance, according to an article published ahead-of-print ...
Jan 10, 2020
0
1
A study in Molecular Oncology indicates that examining the protein and RNA in leftover materials from routine diagnostic tests for breast cancer may lead to more accurate diagnoses.
Jul 18, 2018
0
0
The number of transmen seeking gender-confirming surgery has risen in the past decade. In a paper published in the British Journal of Surgery analysing breast tissue from 344 transmen undergoing mastectomy, breast lesions—either ...
Apr 5, 2018
0
6
Each year, thousands of Canadians are given the news: they have skin cancer. It is the most common form of cancer in Canada and around the world, but if detected early, survival rates are extremely high. According to Liam ...
May 28, 2015
0
7
(HealthDay)—Focal liver lesions (FLLs) are mostly benign, and can be diagnosed based on knowledge of their presentation, associated clinical and laboratory features, and natural history, according to clinical guidelines ...
Aug 28, 2014
0
0
Primary care physicians who took an online training course about skin cancer detection significantly improved their skill to properly diagnose and manage benign and malignant lesions, according to a national study from Henry ...
Nov 7, 2013
0
0
We cannot allow a collective fear of missing bowel cancer to risk unnecessary and harmful treatment of patients with non-cancerous lesions, argue experts in BMJ today.
Oct 8, 2013
0
0
